Literature DB >> 24201376

Differentially localized acyl-CoA synthetase 4 isoenzymes mediate the metabolic channeling of fatty acids towards phosphatidylinositol.

Eva-Maria Küch, Regina Vellaramkalayil, Ingrid Zhang, Daniela Lehnen, Britta Brügger, Wolfgang Sreemmel, Robert Ehehalt, Margarete Poppelreuther, Joachim Füllekrug.   

Abstract

The acyl-CoA synthetase 4 (ACSL4) has been implicated in carcinogenesis and neuronal development. Acyl-CoA synthetases are essential enzymes of lipid metabolism, and ACSL4 is distinguished by its preference for arachidonic acid. Two human ACSL4 isoforms arising from differential splicing were analyzed by ectopic expression in COS cells. We found that the ACSL4_v1 variant localized to the inner side of the plasma membrane including microvilli, and was also present in the cytosol. ACSL4_v2 contains an additional N-terminal hydrophobic region; this isoform was located at the endoplasmic reticulum and on lipid droplets. A third isoform was designed de novo by appending a mitochondrial targeting signal. All three ACSL4 variants showed the same specific enzyme activity. Overexpression of the isoenzymes increased cellular uptake of arachidonate to the same degree, indicating that the metabolic trapping of fatty acids is independent of the subcellular localization. Remarkably, phospholipid metabolism was changed by ACSL4 expression. Labeling with arachidonate showed that the amount of newly synthesized phosphatidylinositol was increased by all three ACSL4 isoenzymes but not by ACSL1. This was dependent on the expression level and the localization of the ACSL4 isoform. We conclude that in our model system exogenous fatty acids are channeled preferentially towards phosphatidylinositol by ACSL4 overexpression. The differential localization of the endogenous isoenzymes may provide compartment specific precursors of this anionic phospholipid important for many signaling processes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24201376     DOI: 10.1016/j.bbalip.2013.10.018

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  40 in total

1.  PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.

Authors:  Chin Fung Kelvin Kan; Amar Bahadur Singh; Bin Dong; Vikram Ravindra Shende; Jingwen Liu
Journal:  Biochim Biophys Acta       Date:  2015-01-31

2.  Anti-Ferroptosis Drug Enhances Total-Body Irradiation Mitigation by Drugs that Block Apoptosis and Necroptosis.

Authors:  Stephanie Thermozier; Wen Hou; Xichen Zhang; Donna Shields; Renee Fisher; Hulya Bayir; Valerian Kagan; Jian Yu; Bing Liu; Ivet Bahar; Michael W Epperly; Peter Wipf; Hong Wang; M Saiful Huq; Joel S Greenberger
Journal:  Radiat Res       Date:  2020-03-05       Impact factor: 2.841

3.  Pseudomonas aeruginosa utilizes host polyunsaturated phosphatidylethanolamines to trigger theft-ferroptosis in bronchial epithelium.

Authors:  Haider H Dar; Yulia Y Tyurina; Karolina Mikulska-Ruminska; Indira Shrivastava; Hsiu-Chi Ting; Vladimir A Tyurin; James Krieger; Claudette M St Croix; Simon Watkins; Erkan Bayir; Gaowei Mao; Catherine R Armbruster; Alexandr Kapralov; Hong Wang; Matthew R Parsek; Tamil S Anthonymuthu; Abiola F Ogunsola; Becca A Flitter; Cody J Freedman; Jordan R Gaston; Theodore R Holman; Joseph M Pilewski; Joel S Greenberger; Rama K Mallampalli; Yohei Doi; Janet S Lee; Ivet Bahar; Jennifer M Bomberger; Hülya Bayır; Valerian E Kagan
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

4.  ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.

Authors:  Sebastian Doll; Bettina Proneth; Yulia Y Tyurina; Elena Panzilius; Sho Kobayashi; Irina Ingold; Martin Irmler; Johannes Beckers; Michaela Aichler; Axel Walch; Holger Prokisch; Dietrich Trümbach; Gaowei Mao; Feng Qu; Hulya Bayir; Joachim Füllekrug; Christina H Scheel; Wolfgang Wurst; Joel A Schick; Valerian E Kagan; José Pedro Friedmann Angeli; Marcus Conrad
Journal:  Nat Chem Biol       Date:  2016-11-14       Impact factor: 15.040

5.  Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis.

Authors:  Valerian E Kagan; Gaowei Mao; Feng Qu; Jose Pedro Friedmann Angeli; Sebastian Doll; Claudette St Croix; Haider Hussain Dar; Bing Liu; Vladimir A Tyurin; Vladimir B Ritov; Alexandr A Kapralov; Andrew A Amoscato; Jianfei Jiang; Tamil Anthonymuthu; Dariush Mohammadyani; Qin Yang; Bettina Proneth; Judith Klein-Seetharaman; Simon Watkins; Ivet Bahar; Joel Greenberger; Rama K Mallampalli; Brent R Stockwell; Yulia Y Tyurina; Marcus Conrad; Hülya Bayır
Journal:  Nat Chem Biol       Date:  2016-11-14       Impact factor: 15.040

Review 6.  Physiological Consequences of Compartmentalized Acyl-CoA Metabolism.

Authors:  Daniel E Cooper; Pamela A Young; Eric L Klett; Rosalind A Coleman
Journal:  J Biol Chem       Date:  2015-06-29       Impact factor: 5.157

7.  The protein and neutral lipid composition of lipid droplets isolated from the fission yeast, Schizosaccharomyces pombe.

Authors:  Alex Meyers; Karuna Chourey; Taylor M Weiskittel; Susan Pfiffner; John R Dunlap; Robert L Hettich; Paul Dalhaimer
Journal:  J Microbiol       Date:  2017-01-26       Impact factor: 3.422

8.  Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.

Authors:  Amar Bahadur Singh; Jingwen Liu
Journal:  J Biol Chem       Date:  2016-12-02       Impact factor: 5.157

9.  Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet.

Authors:  Amar B Singh; Chin Fung K Kan; Fredric B Kraemer; Raymond A Sobel; Jingwen Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-02-05       Impact factor: 4.310

10.  Tissue-Specific Ablation of ACSL4 Results in Disturbed Steroidogenesis.

Authors:  Wei Wang; Xiao Hao; Lina Han; Zhe Yan; Wen-Jun Shen; Dachuan Dong; Kathrin Hasbargen; Stefanie Bittner; Yuan Cortez; Andrew S Greenberg; Salman Azhar; Fredric B Kraemer
Journal:  Endocrinology       Date:  2019-11-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.